openPR Logo
Press release

Erectile Dysfunction Devices Market 2020 Inclinations - by Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical Systems, and Boston Scientific Corporation. etc

03-30-2020 09:55 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Erectile Dysfunction Devices Market

Erectile Dysfunction Devices Market

Erectile dysfunction (ED) also known as impotence, is the inability to get an erection during sexual intercourse. It is a common medical condition in men. Though less common among the younger age group, erectile dysfunction affects 5%-10% of men under 40 years of age. A recent study published in the Journal of Sexual Medicine revealed that one in four patients who sought medical help for erectile dysfunction are under the age of 40 years. Men undergoing cardiovascular or diabetes treatment are at higher risk of developing erectile dysfunction. The condition is strongly related to physical and psychological health. Treatment options include ED drugs, injectable, penile implants, surgery, and vacuum constriction devices.

For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/27

Usually medications such as Sildenafil, Tadalafil, Vardenafil, Avanafil, Alprostadil, and Udenafil are prescribed to treat erectile dysfunction. However, a very small percentage of men are aware of the prevalence of the condition and lower still are the number of people who opt to consult an urologist about it, mainly due to social stigma attached to it. As per a study conducted by the European Association of Urology, only 25% of the men estimated to be suffering from the condition seek medical treatment.

Wide availability of advanced technology devices drives growth of erectile dysfunction devices market

The global erectile dysfunction devices market can be analyzed on the basis of type of device and geography. On the basis of type of device, the global erectile dysfunction devices market is classified as vacuum pumps, penile implants (internal penile pump/inflated pump), vibrators, ED rings, and medicated urethral system (MUSE). Some of the major bands available in the market are Erektor, Viberect, SomaTherapy-ED, Encore, Bonro Medical, and Vacurect.

Vacuum pump, also known as Vacuum Erection device (VED), requires no medication or surgery and is also reimbursed in the U.S. According to the National Health Services, nine out of ten men using vacuum pumps are able to have sex regardless of the underlying cause of ED. Penile implants are medicated devices, which further requires research on its efficacy and safety.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/erectile-dysfunction-devices-market-27

Alternative treatment options hindering growth of erectile dysfunction devices market

Wide availability of effective OTC oral medication such as Viagra adversely impacts demand for erectile dysfunction devices. Also, lack of awareness about proper usage of these devices and pain associated with use, inhibit the growth of erectile dysfunction devices market. Besides, alternative treatment options such as low-intensity extracorporeal shockwave therapy, herbal medicines, and lifestyle changes also limit the demand for ED devices. New technologies such as tissue engineering and nanotechnology are being explored to develop more effective solutions for treatment of erectile dysfunction.

Regional Analysis of Erectile Dysfunction Devices Market

America, Europe, Asia Pacific, Latin America, Africa, and Middle East are major global markets for erectile dysfunction devices. Growing prevalence of ED, increasing awareness about treatment, and high disposable income in developed regions propel the growth of erectile dysfunction devices market. Major marketing activities carried out by various players in the market have contributed largely in creating awareness among the population. However, various device types and their advantages are still not known to healthcare professionals, which in turn results in lower adoption among the general population.

Key Players involved in the erectile dysfunction devices market

There are many regional players operating in this market owing to low entry and exit barriers. Being class 1 and 2 devices and fueled by increasing awareness levels, various players are entering this market. Some of the major players in the global erectile dysfunction devices market are Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical Systems, and Boston Scientific Corporation.

Buy This Premium Research Report https://www.coherentmarketinsights.com/insight/buy-now/27

Key Developments

Key players in the erectile dysfunction devices market are focused on product development and launches in order to expand their consumer base in untapped markets. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED.

Similarly, in August 2019, Ohio, U.S. based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization.

Product approvals by regulatory authorities is also expected to drive growth of the market over the forecast period. For instance, in March 2019, South Korea's Ministry of Food and Drug Safety approved the country's first extracorporeal shock wave equipment, HNT Medical's Carewave which is developed by Medytox Korea.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
sales@coherentmarketinsights.com

U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Devices Market 2020 Inclinations - by Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical Systems, and Boston Scientific Corporation. etc here

News-ID: 1989785 • Views:

More Releases from Coherent Market Insights

Epinephrine Autoinjector Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031 | Mylan, Teva Pharmaceutical, Impax Laboratories
Epinephrine Autoinjector Market Research Report 2024 - Future Opportunities, Lat …
A new Report by Coherent Market Insights, titled "Epinephrine Autoinjector Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2030," offers a comprehensive analysis of the industry, which comprises insights on the Epinephrine Autoinjector market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical
Esophageal Cancer Drugs Market High Growth Opportunities, Emerging Trends, Forecast Till 2031 | GlaxoSmithKline Plc., Novartis AG, Johnson & Johnson
Esophageal Cancer Drugs Market High Growth Opportunities, Emerging Trends, Forec …
A new Report by Coherent Market Insights, titled "Esophageal Cancer Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2030," offers a comprehensive analysis of the industry, which comprises insights on the Esophageal Cancer Drugs market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical
Antihistamine Drugs Market Exploring Future Growth Potential, Developments Factors, Company Performance and Forecast 2031 | Bayer AG, Almirall S.A, GlaxoSmithKline
Antihistamine Drugs Market Exploring Future Growth Potential, Developments Facto …
A new Report by Coherent Market Insights, titled "Antihistamine Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2030," offers a comprehensive analysis of the industry, which comprises insights on the Antihistamine Drugs market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical
Probiotics Reinvented: Navigating the Next Generation Probiotics Market 2024-2031 and its Impact on Gut Health Innovations| Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience
Probiotics Reinvented: Navigating the Next Generation Probiotics Market 2024-203 …
The Latest Report by Coherent Market Insights, titled "Next Generation Probiotics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Next Generation Probiotics market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The Next Generation Probiotics market has been growing significantly in recent years, driven by a number of key

All 5 Releases


More Releases for Erectile

Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E …
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Erectile Dysfunction - Pipeline Review, H2 2017”. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564 The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,